703376008: Product containing canakinumab (medicinal product)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing interleukin receptor antagonist (product)\Product containing interleukin 1 receptor antagonist\Product containing canakinumab

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Product containing canakinumab

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3008369015 Canakinumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3008487016 Canakinumab (product) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3523170012 Product containing canakinumab (medicinal product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3523171011 Product containing canakinumab en Synonym Inactive Entire term case insensitive SNOMED CT core module
3669071017 Canakinumab product en Synonym Inactive Entire term case insensitive SNOMED CT core module
3713749014 Canakinumab-containing product en Synonym Active Entire term case insensitive SNOMED CT core module
107877901000001115 Canakinumab en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing canakinumab	Is a	Product containing monoclonal antibody	true	Inferred relationship	Existential restriction modifier
Product containing canakinumab	Has active ingredient	Canakinumab	true	Inferred relationship	Existential restriction modifier	1
Product containing canakinumab	Is a	Product containing interleukin 1 receptor antagonist	true	Inferred relationship	Existential restriction modifier
Product containing canakinumab	Is a	Virtual therapeutic moiety	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Canakinumab 150mg powder for injection solution	Is a	False	Product containing canakinumab	Inferred relationship	Existential restriction modifier
Canakinumab	Is a	True	Product containing canakinumab	Inferred relationship	Existential restriction modifier
Product containing canakinumab in parenteral dose form (medicinal product form)	Is a	True	Product containing canakinumab	Inferred relationship	Existential restriction modifier
Canakinumab 150mg powder for solution for injection vials	Is a	False	Product containing canakinumab	Inferred relationship	Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials	Is a	False	Product containing canakinumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets